PSAT1 and diffuse large B-cell lymphoma: Notably, two genes showing the largest decrease in expression upon MEN1 inhibition, PSAT1 and SLC1A5, were significantly associated with worse prognosis in a DLBCL patient cohort60 (Supplementary Fig. 8e).